China National Accord Medicines Corp Ltd Cash Flow-to-Debt Ratio
China National Accord Medicines Corp Ltd cash flow-to-debt ratio. China National Accord Medicines Corp Ltd (200028) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of HK$-424.00 Million could theoretically repay 0% of its total liabilities (HK$29.01 Billion) in one year. Check China National Accord Medicines Corp Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of China National Accord Medicines Corp Ltd (1998–2025)
Cash flow-to-debt ratio of China National Accord Medicines Corp Ltd from 1998 to 2025. Historical debt coverage capacity for China National Accord Medicines Corp Ltd across 28 annual periods. Check total reinvestment intensity of China National Accord Medicines Corp Ltd to assess the company's total reinvestment commitment from operating cash flow.
China National Accord Medicines Corp Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
China National Accord Medicines Corp Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for China National Accord Medicines Corp Ltd. For the full cash flow conversion analysis, see 200028 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (HKD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | HK$1.64 Billion | HK$27.47 Billion | ▼ -51.1% |
| 2024 | 0.12x | HK$3.27 Billion | HK$26.80 Billion | ▲ +10.5% |
| 2023 | 0.11x | HK$2.94 Billion | HK$26.59 Billion | ▼ 0.0% |
| 2022 | 0.11x | HK$2.56 Billion | HK$23.17 Billion | ▲ +65.3% |
| 2021 | 0.07x | HK$1.66 Billion | HK$24.76 Billion | ▲ +1.0% |
| 2020 | 0.07x | HK$1.50 Billion | HK$22.71 Billion | ▼ -39.9% |
| 2019 | 0.11x | HK$2.00 Billion | HK$18.16 Billion | ▲ +25.1% |
| 2018 | 0.09x | HK$1.32 Billion | HK$15.02 Billion | ▼ -15.0% |
| 2017 | 0.10x | HK$1.29 Billion | HK$12.42 Billion | ▼ -12.8% |
| 2016 | 0.12x | HK$1.47 Billion | HK$12.40 Billion | ▼ -13.3% |
| 2015 | 0.14x | HK$1.05 Billion | HK$7.65 Billion | ▲ +237.1% |
| 2014 | -0.10x | HK$-796.70 Million | HK$7.98 Billion | ▼ -287.7% |
| 2013 | 0.05x | HK$465.03 Million | HK$8.74 Billion | ▲ +22.5% |
| 2012 | 0.04x | HK$323.96 Million | HK$7.46 Billion | ▲ +19.2% |
| 2011 | 0.04x | HK$227.32 Million | HK$6.24 Billion | ▼ -56.0% |
| 2010 | 0.08x | HK$428.16 Million | HK$5.18 Billion | ▲ +33.0% |
| 2009 | 0.06x | HK$270.85 Million | HK$4.36 Billion | ▼ -23.5% |
| 2008 | 0.08x | HK$246.58 Million | HK$3.03 Billion | ▲ +121.3% |
| 2007 | 0.04x | HK$87.70 Million | HK$2.39 Billion | ▼ -55.4% |
| 2006 | 0.08x | HK$181.73 Million | HK$2.21 Billion | ▼ -62.3% |
| 2005 | 0.22x | HK$148.28 Million | HK$678.73 Million | ▼ -18.2% |
| 2004 | 0.27x | HK$130.30 Million | HK$487.99 Million | ▲ +118.8% |
| 2003 | 0.12x | HK$81.22 Million | HK$665.47 Million | ▲ +204.6% |
| 2002 | 0.04x | HK$28.76 Million | HK$717.90 Million | ▼ -57.6% |
| 2001 | 0.09x | HK$71.16 Million | HK$753.72 Million | ▼ -4.9% |
| 2000 | 0.10x | HK$8.52 Million | HK$85.83 Million | ▼ -62.3% |
| 1999 | 0.26x | HK$22.84 Million | HK$86.72 Million | ▲ +477.0% |
| 1998 | 0.05x | HK$5.21 Million | HK$114.11 Million | — |